Join us for Professor Rohini Sharma’s inaugural lecture online or in person.
There is no need to register to attend so please be sure to use the add to calendar button.
We look forward to seeing you on Wednesday 11 June!
Abstract
Precision cancer medicine aims to tailor treatment to the individual: maximising chances of response whilst avoiding life-threatening side-effects. The liver plays a central role processing prescribed medications but what happens when the liver itself develops cancer or when cancer spreads to the liver? How can treatment be individualised in these settings? Over the last two decades, breakthroughs in molecular imaging, high-throughput technologies and rational drug design have advanced our ability to optimise markers of response.
In this inaugural lecture, Professor Rohini Sharma reflects on her experience in applying these technologies to her clinical practice and research to better understand both liver cancer and neuroendocrine tumours. Her journey integrates personal reflection with scientific discovery, showcasing her work in the pursuit of personalised cancer treatments.
Biography
Professor Rohini Sharma is the first woman to be appointed Professor of Medical Oncology and Clinical Pharmacology at Imperial College London. She is an Honorary Consultant Medical Oncologist at Imperial College Healthcare NHS Trust. After studying medicine at the University of Adelaide, she trained in both Clinical Pharmacology and Medical Oncology in Sydney, Australia. Rohini was awarded a competitive NHMRC postgraduate scholarship to do a PhD at the University of Sydney, Australia. She was successfully nominated for a HEFCE Senior Lecturer post, Imperial College, London. Rohini leads the liver cancer research group where the central theme of her work is improving outcomes in patients with cancer through multidisciplinary, collaborative research. Integral to her work is her commitment to training the next generation of clinician scientists.
